Market Research Logo

Romania Pharmaceuticals and Healthcare Report Q2 2016

Romania Pharmaceuticals and Healthcare Report Q2 2016

BMI View: In line with Romania's economic outperformance in Europe, the country's pharmaceutical andhealthcare markets will see strong growth given increased consumer spending power and higher healthcarecontributions. However, aggressive drug pricing regulations, including the imminent joint drugprocurement agreement with Bulgaria will limit revenue earning opportunities.

Headline Expenditure Projections

Pharmaceuticals: RON14.94bn (USD3.73bn) in 2015 to RON16.16bn (USD3.91bn) in 2016; 8.2% inlocal currency terms and 4.9% in US dollar terms.

Healthcare: RON33.84bn (USD8.45bn) in 2015 to RON34.95bn (USD8.46bn) in 2016; 3.3% in localcurrency terms and 0.2% in US dollar terms.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Romania 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Romania 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Romania 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Romania 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Romania 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Romania 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Romania 2012-2020)
Generic Medicine Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Romania 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Romania 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Romania 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Romania 2014-2020)
Pharmaceuticals & Healthcare Risk/Reward Index
Central And Eastern Europe Risk/Reward Index
Romania Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Corruption
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare System
Table: Healthcare Resources (Romania 2010-2015)
Table: Healthcare Personnel (Romania 2010-2015)
Table: Healthcare Activity (Romania 2010-2015)
Research And Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Members Of ARPIM, 2016
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Antibiotice Iasi
LaborMed Pharma
Terapia Ranbaxy
Demographic Forecast
Table: Population Headline Indicators (Romania 1990-2025)
Table: Key Population Ratios (Romania 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Romania 1990-2025)
Table: Population By Age Group (Romania 1990-2025)
Table: Population By Age Group % (Romania 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report